Author

T. Örd

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:development & morphogenesis· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

M. U. Kaikkonen· 2 shared A. Baker· 1 shared A. Lin· 1 shared A. Misra· 1 shared B. M. Mol· 1 shared C. L. Geczy· 1 shared E. Aavik· 1 shared E. Fisher· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

M. U. Kaikkonen

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Colchicine promotes atherosclerotic plaque stability independently of inflammation

W. Li, A. Lin, M. Hutton, H. Dhaliwal, J. Nadel, J. Rodor, S. Tumanov, T. Örd, M. Hadden, M. Mokry, B. M. Mol, G. Pasterkamp, M. P. Padula, C. L. Geczy, Y. Ramaswamy, , A. Misra

This study shows colchicine stabilizes atherosclerotic plaques by converting harmful SMC-derived cells into protective myofibroblast-like cells, independent of its anti-inflammatory effects.

bioRxiv · Oct 3, 2023 · PreprintCell Biology

ErbB Signalling is a Potential Therapeutic Target for Vascular Lesions with Fibrous Component

H. Ilmonen, S. Jauhiainen, P. Vuola, H. Rasinkangas, H. H. Pulkkinen, S. Keränen, M. Kiema, J. J. Liikkanen, N. Laham-Karam, S. Laidinen, E. Aavik, K. Lappalainen, J. Lohi, J. Aronniemi, T. Örd, , J. P. Laakkonen

This study identifies ErbB signaling as a therapeutic target for vascular lesions with fibrous components by showing TGFA/VEGF-A paracrine signaling and the effect of PIK3CA mutations.

bioRxiv · Sep 23, 2022 · PreprintCell Biology